Literature DB >> 19182301

Very late stent thrombosis after bare-metal stent implantation: case reports and review of the literature.

Gilles Lemesle1, Tina L Pinto Slottow, Ron Waksman.   

Abstract

Stent thrombosis (ST) is a catastrophic complication that frequently presents as an acute myocardial infarction and/or death. The most recently accepted definition established by the Academic Research Consortium classifies ST as: early (occurring within 30 days), late (30 days to 1 year) or very late (after 1 year). Very late ST has been reported following drug-eluting stent implantation with rates up to 0.6% per year and has been attributed to delayed strut endothelialization. However, very late ST is unusual after bare-metal stent (BMS) implantation. We report two cases of patients presenting with ST-elevation myocardial infarction due to very late ST 6 and 8 years after BMS implantation.

Entities:  

Mesh:

Year:  2009        PMID: 19182301

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  4 in total

1.  Probable endothelisation of bare metal stent struts extending from the left main coronary into the aorta.

Authors:  H Zreiqat; C-Y Yang; B James; J Duflou; H C Lowe
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

2.  Very late thrombosis of flow-diverting constructs after the treatment of large fusiform posterior circulation aneurysms.

Authors:  J Klisch; A Turk; R Turner; H H Woo; D Fiorella
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-24       Impact factor: 3.825

Review 3.  Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results.

Authors:  Guillaume Schurtz; Cédric Delhaye; Christopher Hurt; Henri Thieuleux; Gilles Lemesle
Journal:  Med Devices (Auckl)       Date:  2014-02-27

4.  Bare-metal stent thrombosis two decades after stenting.

Authors:  Aynur Acibuca; Demet Menekse Gerede; Veysel Kutay Vurgun
Journal:  Cardiovasc J Afr       Date:  2015-07-23       Impact factor: 1.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.